Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01808976 · ClinicalTrials.gov registry record · NA

Can Mental Health Apps Work in the Real World? A Feasibility Pilot Study.

A NA study of MDD, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
1,000
Enrollment target
1
Study location

NCT01808976: Completed NA study of MDD, sponsored by University of California, San Francisco.

NCT01808976 is a NA study of MDD that has completed, run by University of California, San Francisco. The registered enrollment target is 1,000 participants, above the 66-participant average among 7 other MDD trials with a reported enrollment target (1415% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01808976, a NA study of MDD, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
1,000 participants
Enrollment target
1
Study location

Study Summary

Over two million people in the US download health apps onto their smartphones and tablets, with the intent of improving their quality of life. Despite widespread use of these apps, there is relatively little information regarding app user access (do users download health apps and use them more than once), app user engagement (do users follow the app protocols) and app impact on mood, cognition and daily functioning. Our long-term goal is to conduct a future randomized controlled trial investigating access, engagement and impact of two types of mental health apps, apps based on evidence-based therapeutic principles (i.e.: Problem Solving Therapy) and apps based on cognitive neuroscience principles of depression (i.e.: a cognitive training game called Evolution) and compare both to an information only app. Our intent is to conduct this study entirely on mobile devices, in order to investigate access, engagement, and impact in an ecologically valid manner. The purpose of this pilot study is to test the feasibility of conducting our future randomized controlled trial comparing three mobile mental health apps for the management of depressed mood, improvement of cognitive control, and improvement in activities of daily living in people aged 18 and older. Recruitment, consent, randomization, app use and outcome assessment will be conducted entirely on mobile devices. We will recruit 150 people through four different recruitment avenues to determine which avenue results in the most representative sample of our target population (people 18 and older who have symptoms of depression that are interfering with their quality of life). We will also determine the number we need to recruit to have a final sample of 150 people willing to be randomized between the 3 apps and complete an 12-week study of app impact on mood, cognition and function. This pilot will provide information on the completeness of data from a study conducted in this manner, and uncover any other challenges we m

Primary Outcome

Assesses functional impairment in three inter-related domains; work/school, social and family life.

Conditions Studied

Interventions

  • OTHER Problem Solving Therapy
  • BEHAVIORAL Evolution
  • BEHAVIORAL Basic health push app

Study Locations (1)

California

  • Web-based; log onto www.brightenstudy.com/spa for details - San Francisco

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2013-04
Est. Completion 2017-02
Phase NA

What the finished NCT01808976 record still lists

NCT01808976 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 66-participant average among 7 other MDD trials with a reported enrollment target (1415% higher).

The record links to 1 condition, with MDD appearing as the primary indexed condition, and to 3 interventions - of which Problem Solving Therapy is the first listed.

NCT01808976 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01808976 about?

NCT01808976 is a clinical study titled "Can Mental Health Apps Work in the Real World? A Feasibility Pilot Study.". Over two million people in the US download health apps onto their smartphones and tablets, with the intent of improving their quality of life. Despite widespread use of these apps, there is relatively little information regarding app user access (do users download health apps and use them more than ...

What is the current status of trial NCT01808976?

This trial is currently completed. It is a NA study. The enrollment target is 1,000 participants. The study started on 2013-04. Estimated completion is 2017-02.

What conditions does trial NCT01808976 study?

This clinical trial studies the following conditions: MDD.

What interventions are being tested in trial NCT01808976?

The interventions under investigation include: Problem Solving Therapy (OTHER), Evolution (BEHAVIORAL), Basic health push app (BEHAVIORAL).

Who is sponsoring clinical trial NCT01808976?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01808976 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for MDD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01808976, the US trial registry maintained by the National Library of Medicine. NCT01808976 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.